Related Experiment Video
Updated: Aug 15, 2026
09:04
Recording Gamma Band Oscillations in Pedunculopontine Nucleus Neurons
Published on: September 14, 2016
Buspirone increases locus coeruleus noradrenergic neuronal activity in vitro
European Journal of Pharmacology
|October 30, 1984
Summary
Buspirone directly increases the activity of norepinephrine neurons in the locus coeruleus. This suggests that these noradrenergic neurons may play a less significant role in anxiety than previously believed.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Buspirone is a non-benzodiazepine anxiolytic.
- The role of noradrenergic neurons in anxiety is debated.
Purpose of the Study:
- To investigate the direct effect of buspirone on locus coeruleus neurons.
- To assess the involvement of noradrenergic pathways in anxiety mediation.
Main Methods:
- In vitro recording of norepinephrine-containing locus coeruleus neurons from mouse brain slices.
- Application of buspirone at varying concentrations.
- Incubation in low calcium/high magnesium medium to assess direct neuronal action.
Main Results:
- Buspirone demonstrated dose-dependent increases in locus coeruleus neuronal activity.
- The observed effects persisted in a modified incubation medium, confirming direct action.
- Noradrenergic neurons showed increased activity in response to buspirone.
Conclusions:
- Buspirone directly stimulates norepinephrine-containing locus coeruleus neurons.
- Noradrenergic neurons may have a less critical role in mediating anxiety than previously hypothesized.
- Findings challenge existing models of anxiety pathophysiology.
Related Concept Videos
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
01:22CNS Stimulants: Psychedelic Agents
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
01:26Anxiolytic Drugs: Overview
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
01:29Anxiolytic Drugs: Benzodiazepines and Buspirone
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...